References
- Andreasson B, Nyboe J (1985). Value of prognostic parameters in squamous cell carcinoma of the vulva. Gynecol Oncol, 22, 341-51. https://doi.org/10.1016/0090-8258(85)90049-6
- Bell JG, Lea JS, Reid GC (2000). Complete groin lymphadenectomy with preservation of the fascia lata in the treatment of vulvar carcinoma. Gynecol Oncol, 77, 314-8. https://doi.org/10.1006/gyno.2000.5790
- Burger MP, Hollema H, Emanuels AG, et al (1995). The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol, 57, 327-34. https://doi.org/10.1006/gyno.1995.1151
- Chan JK, Sugiyama V, Pham H, et al (2007). Margin distance and other clinicopathologic prognostic factors in vulvar carcinoma: A multivariate analysis. Gynecol Oncol, 104, 636-41. https://doi.org/10.1016/j.ygyno.2006.10.004
- Gadducci A, Cionini L, Romanini A, Fanucchi A, Genazzani AR (2006). Old and new perspectives in the management of highrisk, locally advanced or recurrent, and metastatic vulvar cancer. Crit Rev Oncol Hematol, 60, 227-41. https://doi.org/10.1016/j.critrevonc.2006.06.009
- Gonzalez Bosquet J, Magrina JF, Gaffey TA, et al (2005). Long-term survival and disease recurrence in patients with primary squamous cell carcinoma of the vulva. Gynecol Oncol, 97, 828-33. https://doi.org/10.1016/j.ygyno.2005.03.006
- Hacker NF, Berek JS, Lagasse LD, Leuchter RS, Moore JG (1983). Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet Gynecol, 61, 408-12.
- Hampl M, Kueppers V, Bender HG (2009). Single large inguinal lymph node metastasis in human papillomavirus-induced early invasive vulvar cancer of the anterior fourchette in two young women. Gynecol Obstet Invest, 67, 42-5. https://doi.org/10.1159/000159178
- Hefler L, Obermair A, Tempfer C, et al (1999). Serum concentrations of squamous cell carcinoma antigen in patients with vulvar intraepithelial neoplasia and vulvar cancer. Int J Cancer, 84, 299-303. https://doi.org/10.1002/(SICI)1097-0215(19990621)84:3<299::AID-IJC17>3.0.CO;2-K
- Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER web site, 2012.
- Iversen T, Aalders JG, Christensen A, Kolstad P (1980). Squamous cell carcinoma of the vulva: A review of 424 patients, 1956-1974. Gynecol Oncol, 9, 271-9. https://doi.org/10.1016/0090-8258(80)90038-4
- Kelley 3rd JL, Burke TW, Tornos C, et al (1992). Minimally invasive vulvar carcinoma: an indication for conservative surgical therapy. Gynecol Oncol, 44, 240-4. https://doi.org/10.1016/0090-8258(92)90050-S
- Lataifeh I, Carraro Nascimento M, Nicklin JL, et al (2004). Patterns of recurrence and disease-free survival in advanced squamous cell carcinoma of the vulva. Gynecol Oncol, 95, 701-5. https://doi.org/10.1016/j.ygyno.2004.08.015
- Magrina JF, Webb MJ, Gaffey TA, Symmonds RE (1979). Stage I squamous cell cancer of the vulva. Am J Obstet Gynecol, 134, 453-9.
- Oonk MH, de Hullu JA, van der Zee AG (2010). Current controversies in the management of patients with early-stage vulvar cancer. Curr Opin Oncol, 22, 481-6. https://doi.org/10.1097/CCO.0b013e32833c06da
- Origoni M, Sideri M, Garsia S, Carinelli SG, Ferrari AG (1992). Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO. Gynecol Oncol, 45, 313-6. https://doi.org/10.1016/0090-8258(92)90311-6
- Paladini D, Cross P, Lopes A, Monaghan JM (1994). Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva. Cancer, 74, 2491-6. https://doi.org/10.1002/1097-0142(19941101)74:9<2491::AID-CNCR2820740916>3.0.CO;2-5
- Podratz KC, Symmonds RE, Taylor WF, Williams TJ (1983). Carcinoma of the vulva: Analysis of treatment and survival. Obstet Gynecol, 61, 63-74.
- Rodolakis A, Diakomanolis E, Voulgaris Z, et al (2000). Squamous vulvar cancer: a clinically based individualization of treatment. Gynecol Oncol, 78, 346-51. https://doi.org/10.1006/gyno.2000.5882
- Sidor J, Diallo-Danebrock R, Eltze E, Lelle RJ (2006). Challenging the concept of microinvasive carcinoma of the vulva: report of a case with regional lymph node recurrence and review of the literature. BMC Cancer, 6, 157. https://doi.org/10.1186/1471-2407-6-157
- Van der Velden J, van Lindert AC, Lammes FB, et al (1995). Extracapsular growth of lymph node metastases in squamous cell carcinoma of the vulva. The impact on recurrence and survival. Cancer, 75, 2885-90. https://doi.org/10.1002/1097-0142(19950615)75:12<2885::AID-CNCR2820751215>3.0.CO;2-3
- Van der Zee AG, Oonk MH, De Hullu JA, et al (2008). Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol, 26, 884-9. https://doi.org/10.1200/JCO.2007.14.0566
- Woelber L, Mahner S, Voelker K, et al (2009). Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer. Anticancer Res, 29, 545-52.
- Woolderink JM, de Bock GH, de Hullu JA, et al (2006). Patterns and frequency of recurrences of squamous cell carcinoma of the vulva. Gynecol Oncol, 103, 293-9. https://doi.org/10.1016/j.ygyno.2006.03.010
Cited by
- Study of Biomolecular and Clinical Prognostic Factors in Patients With Cancer of the Vulva Undergoing Surgical Treatment vol.24, pp.4, 2014, https://doi.org/10.1097/IGC.0000000000000103
- Current insights into the aetiology, pathobiology, and management of local disease recurrence in squamous cell carcinoma of the vulva vol.124, pp.6, 2017, https://doi.org/10.1111/1471-0528.14560